BioSpace News Archive

Biotech Beach

Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

The grant made January 3, 2018 is an award of a nonstatutory stock option to purchase 1,588,832 of Vital Therapies’ common stock.

January 5, 2018
·
1 min read
Drug Development

Neurotrope’s Bryostatin Improves Cognition in Patients With Advanced Alzheimer’s Disease Based on Further Analysis of Phase II Clinical Trial Data

The findings suggest this investigational drug could potentially help treat the progression of AD, rather than only its symptoms.

January 5, 2018
·
9 min read
Business

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

Distributed Bio announce an agreement with Pfizer Inc. to license the Distributed Bio SuperHuman Platform for the identification of novel antibodies for use as therapeutic agents.

January 5, 2018
·
3 min read
Business

Datavant Selects the Duke Clinical Research Institute as Founding Academic Partner to Accelerate Innovation in Data-Driven Clinical Research

Datavant announced today that it has selected the Duke Clinical Research Institute, the world’s largest academic clinical research organization, as an analytical partner to accelerate data-driven approaches in drug development.

January 5, 2018
·
2 min read
Business

Longtime CEO at Bay Area’s OncoMed Steps Down

Board of Directors has initiated search to identify successor.

January 5, 2018
·
4 min read
Pharm Country

NovoPath Anatomic Pathology Software System Integrates With Philips IntelliSite Pathology Solution and Wholeslide Imaging System

NovoPath announces the integration of the NovoPath Anatomic Pathology Software Platform with Philips IntelliSite Pathology Solution and Wholeslide Imaging System.

January 5, 2018
·
2 min read
Biotech Beach

NantKwest to Host 3rd Annual Investor/Analyst Day Highlighting a Record Number of 15 INDs Authorized in 2017 Covering 12 Tumor Types with First In-Human Clinical Data of Safety and Early Signs of Clinical Activity of the NANT Cancer Vaccine

NantKwest announced today that the company will be hosting an Investor/Analyst Day on Tuesday, January 9th in San Francisco, California.

January 5, 2018
·
3 min read
Policy

IDEXX Announces Estimated Impact of U.S. Tax Reform

IDEXX expects the recently passed Tax Cuts and Jobs Act to benefit the Company by reducing its recurring effective tax rate beginning in 2018 by approximately 750-850 basis points.

January 5, 2018
·
3 min read